Antibody molecules having specificity for human IL-1beta
Details for Australian Patent Application No. 2004210776 (hide)
International Classifications
Event Publications
1 September 2005 PCT application entered the National Phase
PCT publication WO2004/072116 Priority application(s): WO2004/072116
14 February 2008 Assignment before Grant
Celltech R&D Limited The application has been assigned to UCB Pharma S.A.
7 April 2011 Application Accepted
Published as AU-B-2004210776
4 August 2011 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2004210779-Isoxazole compounds as inhibitors of heat shock proteins
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
![](/images/main/3dbox_small.png)
- Editable Word format reports
- For IP Professionals
- Multiuser